N Verses Capital, LLC I Teos Therapeutics, Inc. Transaction History

N Verses Capital, LLC

  • $0
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$10.09 - $17.97 $17,153 - $30,548
1,700 Added 212.5%
2,500 $25.5 Million
Q2 2024

Jul 31, 2024
BUY
$10.33 - $18.09 $3,099 - $5,427
300 Added 60.0%
800 $11.9 Million
Q1 2024

Apr 25, 2024
BUY
$9.89 - $13.64 $4,945 - $6,820
500 New
500 $6.82 Million

Others Institutions Holding ITOS

# of Institutions
150
Shares Held
33.4M
Call Options Held
454K
Put Options Held
2.45M
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $245M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email